US-based commercial services provider Eversana has announced a strategic alliance with China Resource Pharmaceutical Commercial Group. The collaboration aims to expand access to healthcare solutions, including both drugs and devices, with a focus on global products entering the Chinese market and domestic companies expanding into overseas markets.
Enhancing Healthcare Innovation and Access in China
Eversana’s APAC Consulting team will offer thought leadership and strategic advisory support to pharmaceutical companies looking to commercialize therapies in the region. This expertise, combined with China Resource’s extensive commercial network and knowledge, will be instrumental in supporting healthcare innovation in China and improving access to global medical products entering the country.
Mutual Benefits and Global Expansion
China Resource views the partnership as an opportunity to gain access to international markets and attract global clients. Additionally, the alliance will support domestic manufacturers in China seeking to expand their reach on the global stage. This strategic alliance is expected to benefit both parties by leveraging their respective strengths and resources to enhance the accessibility and quality of healthcare solutions worldwide.-Fineline Info & Tech
